Management of Recurrent Subdural Hematoma

Introduction to Arteriovenous Malformations (AVMs)

• AVMs are complex vascular lesions that require careful management to prevent hemorrhage and other complications, with treatment decisions guided by a risk assessment that considers AVM characteristics, patient factors, and hemorrhage risk, as recommended by the American Heart Association 1
• The annual hemorrhage risk for unruptured AVMs is 2-4% per year, with factors such as prior hemorrhage, deep brain location, and exclusive deep venous drainage increasing the risk of hemorrhage 1
• Lifetime hemorrhage risk calculation is 105 - (patient's age in years) 1, 2

Risk Factors for Hemorrhage

• Deep or periventricular location is a risk factor for hemorrhage in patients with DAVFs, according to the American Heart Association and American Stroke Association 3, 1
• Additional risk factors for hemorrhage include prior hemorrhage, deep location, deep venous drainage, intranidal aneurysms, and small AVM size 1, 2
• Patients with a history of hemorrhage have a 6-32.9% risk of rebleeding in the first year after initial hemorrhage, and 11.3% in subsequent years, as reported by the American Heart Association 3, 1
• The risk of rebleeding increases to approximately 25% in the first year after a second hemorrhage, based on guidelines from the American Association of Neurological Surgeons 2

Diagnostic Imaging

• MRI is the preferred imaging modality over CT for diagnosing arteriovenous malformations due to its superior sensitivity, better tissue characterization, and ability to detect AVMs even in the presence of hemorrhage, as recommended by the American College of Radiology 4, 3
• MRI demonstrates superior sensitivity and better tissue characterization, allowing for the detection of AVMs even in the presence of hemorrhage, with a sensitivity of 89-97% 4
• Digital subtraction angiography (DSA) remains the gold standard for definitive diagnosis, providing the highest spatial and temporal resolution, as stated by the American College of Radiology and the Stroke journal 4, 3

1

Treatment Options

• Complete surgical excision is the recommended approach for accessible AVMs, as it provides immediate cure with elimination of hemorrhage risk, according to the American Heart Association 1
• Microsurgical resection is recommended as first-line treatment for accessible AVMs (Spetzler-Martin grades I-II), providing immediate cure with 92-100% favorable outcomes for grade I and 95% for grade II lesions, and potential improvement in seizure control (83% become seizure-free within 2 years) 2
• Stereotactic radiosurgery is best for small AVMs (<3 cm diameter, <10 cm³ volume) in eloquent areas, with complete obliteration occurring in ~80% of cases within 2-3 years, but with delayed protection and a 5-7% risk of treatment-related complications 1
• Embolization is rarely used as standalone treatment, but may be indicated for pre-surgical embolization, targeted embolization of high-risk features, component of multimodality treatment, or palliative treatment for incurable symptomatic AVMs 2
• Conservative management may be considered for high-grade AVMs (Spetzler-Martin grades IV-V) or elderly patients with limited life expectancy, requiring regular monitoring with imaging and neurological examinations 2

Management and Follow-up

• Regular follow-up imaging is necessary to confirm complete AVM obliteration and monitor for signs of recurrence or complications, with assessment of seizure control and maintenance of normotensive blood pressure 2
• Maintenance of normotensive blood pressure is also recommended, and regular neurological examinations, repeat imaging to assess for AVM changes, ongoing assessment of seizure control, and monitoring for signs of hemorrhage or progressive neurological deficits are essential in managing patients with AVMs 1
• Antiepileptic therapy should be considered if seizure activity is suspected as the mechanism of syncope in AVM patients, and AVM obliteration may reduce seizure frequency, as recommended by the American Academy of Neurology 3

Special Considerations

• The American College of Obstetricians and Gynecologists recommends that treatment should be considered prior to conception if an AVM is discovered before pregnancy, and risk-benefit analysis rarely supports elective treatment during pregnancy 3
• The American Academy of Pediatrics recommends that higher lifetime hemorrhage risk must be balanced against treatment-related morbidity in pediatric patients, with more common findings in eloquent locations and higher rates of morbidity and mortality compared to adult series 3
• Incomplete risk assessment that fails to consider all patient and AVM characteristics should be avoided, as well as partial embolization without a definitive treatment plan, lack of regular follow-up imaging to confirm complete obliteration, and ignoring patient-specific factors like age, comorbidities, and functional status 1, 2